Phillip Palmbos

6PUBLICATIONS
52CO-AUTHORS
Biomechanical engineeringMolecular targetsTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 04, 2026
TRIM29 is Critical for Bladder Cancer Progression and Modulates the Tumor-Immune Niche.

|Sep 16, 2025
Multicenter Phase II Study of Olaparib and the ATR Inhibitor Ceralasertib in Metastatic Castration-Resistant Prostate Cancer (TRAP).

Irene Tsung, David C Smith, Elisabeth I Heath

|Sep 04, 2025
TRIM29 promotes bladder cancer invasion by regulating the intermediate filament network and focal adhesion.

Yin Wang, Nicole A Jerome, Alan J Kelleher

|Aug 01, 2024
Sacituzumab Govitecan Demonstrates Efficacy across Tumor Trop-2 Expression Levels in Patients with Advanced Urothelial Cancer.

Yohann Loriot, Arjun V Balar, Daniel P Petrylak

|May 24, 2024
Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial.

Charles B Nguyen, Melissa A Reimers, Chamila Perera

|Jan 03, 2024
TRIM29 promotes bladder cancer invasion by regulating the intermediate filament network and focal adhesion.

Phillip Palmbos, Yin Wang, Nicole Jerome

Pageof 1

Frequent Collaborators

2 joint publications

Charles B Nguyen

2 joint publications

Elisabeth I Heath

2 joint publications

Ulka Vaishampayan

2 joint publications

Megan E V Caram